We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UBS Group AG Eyes $1B Loan Risk Transfer to Ease Capital Strain
Read MoreHide Full Article
Key Takeaways
UBS Group AG is in talks for a $1B significant risk transfer tied to corporate loans.
The deal would help manage rising capital demands under proposed Swiss regulations.
UBS has achieved $9.1B in cost savings and merged 95 branches amid Credit Suisse integration.
UBS Group AG (UBS - Free Report) is reportedly in early discussions with investors for a potential significant risk transfer (SRT) tied to a $1 billion portfolio of corporate loans. The move comes as the bank seeks to manage stricter capital requirements proposed by regulators following the Credit Suisse collapse, per a Bloomberg article published on MSN.
The SRT could represent around 12.5% of the reference portfolio, though the final size and structure remain under discussion. In addition, the company is exploring another SRT deal linked to CHF 2 billion ($2.5 billion) of loans, which could be issued through J-Elvetia, a structure previously used by Credit Suisse for similar transactions before being acquired by UBS. These moves enable banks to transfer credit risk to institutional investors, thereby freeing up regulatory capital for other strategic uses.
UBS’ Capital Optimization Amid Tougher Swiss Rules
The discussion comes amid a broader regulatory shift in Switzerland. In June 2025, the Federal Department of Finance proposed that UBS increase the capital held in its foreign subsidiaries to the fully required level compared with the current 60% threshold. The reform aims to prevent a repeat of the Credit Suisse crisis by ensuring UBS maintains sufficient equity across all international units.
If implemented, these reforms could raise UBS’s total capital needs by up to $26 billion. By transferring portions of its loan-related credit risk to institutional investors through SRT deals, UBS aims to free up regulatory capital, providing more flexibility to support lending, integration efforts and shareholder returns.
UBS’s Credit Suisse Integration Progress
UBS continues to progress well with its large-scale integration of Credit Suisse, achieving significant milestones on both cost and capital targets. As part of its restructuring, the bank’s Non-Core and Legacy business has reduced risk-weighted assets (RWA) by 62%, well ahead of schedule. It now aims to further reduce Non-Core and Legacy RWAs to below $8 billion by the end of 2025 and around $1.6 billion by 2026, which is expected to release more than $6 billion in capital.
Apart from these asset reductions, UBS has achieved roughly $9.1 billion in cost savings, representing 70% of its $13 billion goal by 2026. The bank has also merged 95 branches in Switzerland and migrated more than 90% of its Global Wealth Management client accounts outside Switzerland, including those in Luxembourg, Hong Kong, Singapore and Japan, onto its platforms. It remains focused on completing the main phase of Swiss client migrations by the end of the first quarter of 2026.
UBS’ Zacks Rank & Price Performance
Over the past six months, UBS shares have gained 56.6% compared with the industry’s growth of 42.2%.
Image Source: Zacks Investment Research
Currently, the company carries a Zacks Rank #2 (Buy).
The earnings estimates for BCS for the current year have been revised 1.3% upward over the past seven days. Over the past six months, BCS shares have soared 61.1%.
NTB’s current fiscal-year earnings estimates have remained unchanged over the past seven days. Shares of NTB have gained 17.7% over the past six months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
UBS Group AG Eyes $1B Loan Risk Transfer to Ease Capital Strain
Key Takeaways
UBS Group AG (UBS - Free Report) is reportedly in early discussions with investors for a potential significant risk transfer (SRT) tied to a $1 billion portfolio of corporate loans. The move comes as the bank seeks to manage stricter capital requirements proposed by regulators following the Credit Suisse collapse, per a Bloomberg article published on MSN.
The SRT could represent around 12.5% of the reference portfolio, though the final size and structure remain under discussion. In addition, the company is exploring another SRT deal linked to CHF 2 billion ($2.5 billion) of loans, which could be issued through J-Elvetia, a structure previously used by Credit Suisse for similar transactions before being acquired by UBS. These moves enable banks to transfer credit risk to institutional investors, thereby freeing up regulatory capital for other strategic uses.
UBS’ Capital Optimization Amid Tougher Swiss Rules
The discussion comes amid a broader regulatory shift in Switzerland. In June 2025, the Federal Department of Finance proposed that UBS increase the capital held in its foreign subsidiaries to the fully required level compared with the current 60% threshold. The reform aims to prevent a repeat of the Credit Suisse crisis by ensuring UBS maintains sufficient equity across all international units.
If implemented, these reforms could raise UBS’s total capital needs by up to $26 billion. By transferring portions of its loan-related credit risk to institutional investors through SRT deals, UBS aims to free up regulatory capital, providing more flexibility to support lending, integration efforts and shareholder returns.
UBS’s Credit Suisse Integration Progress
UBS continues to progress well with its large-scale integration of Credit Suisse, achieving significant milestones on both cost and capital targets. As part of its restructuring, the bank’s Non-Core and Legacy business has reduced risk-weighted assets (RWA) by 62%, well ahead of schedule. It now aims to further reduce Non-Core and Legacy RWAs to below $8 billion by the end of 2025 and around $1.6 billion by 2026, which is expected to release more than $6 billion in capital.
Apart from these asset reductions, UBS has achieved roughly $9.1 billion in cost savings, representing 70% of its $13 billion goal by 2026. The bank has also merged 95 branches in Switzerland and migrated more than 90% of its Global Wealth Management client accounts outside Switzerland, including those in Luxembourg, Hong Kong, Singapore and Japan, onto its platforms. It remains focused on completing the main phase of Swiss client migrations by the end of the first quarter of 2026.
UBS’ Zacks Rank & Price Performance
Over the past six months, UBS shares have gained 56.6% compared with the industry’s growth of 42.2%.
Image Source: Zacks Investment Research
Currently, the company carries a Zacks Rank #2 (Buy).
Other Foreign Bank Stocks Worth Considering
A couple of other top-ranked foreign banks are Barclays PLC (BCS - Free Report) and The Bank of N.T. Butterfield & Son Limited (NTB - Free Report) . Each stock presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The earnings estimates for BCS for the current year have been revised 1.3% upward over the past seven days. Over the past six months, BCS shares have soared 61.1%.
NTB’s current fiscal-year earnings estimates have remained unchanged over the past seven days. Shares of NTB have gained 17.7% over the past six months.